Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 04:00PM ET
23.01
Dollar change
-2.74
Percentage change
-10.64
%
Index- P/E- EPS (ttm)- Insider Own31.76% Shs Outstand44.40M Perf Week-7.07%
Market Cap1.02B Forward P/E- EPS next Y- Insider Trans51.93% Shs Float30.30M Perf Month-11.50%
Income- PEG- EPS next Q-0.69 Inst Own31.19% Short Float1.80% Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Ratio1.81 Perf Half Y-
Book/sh-1.97 P/B- EPS next Y- ROA- Short Interest0.55M Perf Year-
Cash/sh2.94 P/C7.83 EPS next 5Y- ROE- 52W Range18.62 - 27.47 Perf YTD7.52%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-16.24% Beta-
Dividend TTM- Quick Ratio10.08 Sales past 5Y0.00% Gross Margin- 52W Low23.58% ATR (14)2.10
Dividend Ex-Date- Current Ratio10.08 EPS Y/Y TTM- Oper. Margin- RSI (14)48.27 Volatility9.22% 8.19%
Employees- Debt/Eq0.18 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price43.67
Option/ShortNo / Yes LT Debt/Eq0.18 EPS Q/Q- Payout- Rel Volume1.02 Prev Close25.75
Sales Surprise50.00% EPS Surprise-42.94% Sales Q/Q- EarningsNov 20 BMO Avg Volume302.12K Price23.01
SMA20-3.98% SMA50-2.38% SMA200-2.38% Trades Volume308,952 Change-10.64%
Date Action Analyst Rating Change Price Target Change
Nov-19-24Initiated Wells Fargo Overweight $43
Nov-19-24Initiated TD Cowen Buy
Nov-19-24Initiated JP Morgan Overweight $38
Nov-19-24Initiated Cantor Fitzgerald Overweight $50
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RA CAPITAL MANAGEMENT, L.P.DirectorOct 28 '24Buy18.004,170,00075,060,0005,523,915Oct 30 06:12 PM
Third Rock Ventures V, L.P.10% OwnerOct 28 '24Buy18.00370,5006,669,0006,215,591Oct 28 04:53 PM
Third Rock Ventures V, L.P.10% OwnerOct 28 '24Buy18.00279,5005,031,0003,152,456Oct 28 04:53 PM